Jonathan Young
CIK 1779805 · Chief Operating Officer · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
61
Lifetime Open-Market Net
-$13.41M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Operating Officer | 0 | $54.65 | $0 | -$13.41M | 61 | 2025-12-09 |
Recent Filings · Page 3 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −568 | -$14.9K | EDGAR |
| 2024-09-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −5,000 | -$133.6K | EDGAR |
| 2024-08-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −5,000 | -$133.8K | EDGAR |
| 2024-07-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −3,936 | -$95.8K | EDGAR |
| 2024-06-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −2,516 | -$57.0K | EDGAR |
| 2024-06-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −5,000 | -$96.4K | EDGAR |
| 2024-05-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −5,000 | -$100.7K | EDGAR |
| 2024-04-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −5,000 | -$121.9K | EDGAR |
| 2024-03-15 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −651 | -$18.4K | EDGAR |
| 2024-03-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Exer (M) | +83,321 | $51.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.